SCHEMBL5487220

SCHEMBL5487220

Nc1ccc2ncccn12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 1/20 0.42
CDK8 P49336 2/20 0.36
ROCK1 Q13464 2/20 0.36
DYRK1A Q13627 2/20 0.36
CHEK1 O14757 1/20 0.36
MAP4K4 O95819 1/20 0.36
CSF1R P07333 1/20 0.36
PRKACA P17612 1/20 0.36
KDR P35968 1/20 0.36
MAP2K1 Q02750 1/20 0.36
ACVR1 Q04771 1/20 0.36
MAP4K2 Q12851 1/20 0.36
AURKB Q96GD4 1/20 0.36
DYRK1B Q9Y463 1/20 0.36
BACE1 P56817 1/20 0.35
CDK4 P11802 1/20 0.35
CDK2 P24941 1/20 0.35
HSP90AA1 P07900 1/20 0.35
NOS3 P29474 2/20 0.34
NOS1 P29475 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL334306 0.78 CDK8 (0.53) ADORA3CDK8ROCK1DYRK1ACHEK1
Hydrochloric Acid SCHEMBL5442637 0.77 CDK8 (0.52) ADORA3CDK8ROCK1DYRK1ACHEK1
Bromide SCHEMBL9692647 0.77 CDK8 (0.52) ADORA3CDK8ROCK1DYRK1ACHEK1
SCHEMBL19153793 0.74 ADORA3 (0.42) ADORA3CDK8ROCK1DYRK1ACHEK1
SCHEMBL335455 0.70 PKM (0.51) ADORA3DYRK1ACDK4CDK2PKM
SCHEMBL5487082 0.70 SMPD3 (0.38) ADORA3CDK8ROCK1DYRK1ACHEK1
SCHEMBL17624867 0.69 ADORA3 (0.39) ADORA3CDK8ROCK1DYRK1ACHEK1
SCHEMBL12604003 0.69 ADORA3 (0.39) ADORA3CDK8ROCK1DYRK1ACHEK1
SCHEMBL18237866 0.69 ADORA3 (0.43) ADORA3CDK8ROCK1DYRK1ACHEK1
SCHEMBL3250642 0.68 APOBEC3A (0.45) ADORA3CDK8ROCK1DYRK1ACHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7306631-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2007-12-11 US disclosed
EP-1732509-A1 KERATIN DYEING COMPOSITIONS BICYCLIC 5-6 HETEROAROMATIC DYEING COMPOUNDS WITH ONE RING NITROGEN JUNCTION The Procter and Gamble Company (US) 2006-12-20 EP disclosed
WO-2005097052-A1 KERATIN DYEING COMPOSITIONS BICYCLIC 5-6 HETEROAROMATIC DYEING COMPOUNDS WITH ONE RING NITROGEN JUNCTION THE PROCTER & GAMBLE COMPANY (US) 2005-10-20 WO disclosed
US-20050229333-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER & GAMBLE COMPANY, THE 2005-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050229333-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof KRT18, CKMT1A; CKMT1B, JUP ADORA3 4765/4885CDK8 1229/4885ROCK1 2754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.